Gainers
- Jasper Therapeutics (NASDAQ:JSPR) stock rose 32.1% to $2.18 during Friday's pre-market session. The market value of their outstanding shares is at $80.8 million.
- Redhill Biopharma (NASDAQ:RDHL) shares increased by 19.69% to $0.2. The company's market cap stands at $18.6 million.
- Biomea Fusion (NASDAQ:BMEA) stock rose 19.66% to $8.64. The market value of their outstanding shares is at $253.9 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 12.43% to $1.99. The company's market cap stands at $26.9 million.
- Benitec Biopharma (NASDAQ:BNTC) stock rose 11.79% to $0.22. The market value of their outstanding shares is at $6.2 million.
- NGM Biopharmaceuticals (NASDAQ:NGM) shares increased by 11.48% to $5.63. The market value of their outstanding shares is at $460.1 million.
Losers
- Catalyst Biosciences (NASDAQ:CBIO) shares decreased by 52.4% to $0.3 during Friday's pre-market session. The company's market cap stands at $11.3 million.
- VYNE Therapeutics (NASDAQ:VYNE) shares fell 11.55% to $0.25. The company's market cap stands at $14.5 million.
- Landos Biopharma (NASDAQ:LABP) shares decreased by 8.92% to $0.38. The market value of their outstanding shares is at $15.4 million.
- Assure Hldgs (NASDAQ:IONM) stock decreased by 8.77% to $0.31. The market value of their outstanding shares is at $6.3 million.
- Altimmune (NASDAQ:ALT) shares fell 8.44% to $15.41. The market value of their outstanding shares is at $757.5 million.
- eFFECTOR Therapeutics (NASDAQ:EFTR) shares fell 8.17% to $0.4. The company's market cap stands at $16.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BMEABiomea Fusion Inc
$1.40-0.71%
BNTCBenitec Biopharma Inc
$11.68-%
CBIOCrescent Biopharma Inc
$13.51-%
EFTReFFECTOR Therapeutics Inc
$0.00020-99.9%
IONMAssure Holdings Corp
$0.000001-100.0%
JSPRJasper Therapeutics Inc
$1.540.65%
RDHLRedhill Biopharma Ltd
$1.36-%
SHPHShuttle Pharmaceuticals Holdings Inc
$1.799.78%
VYNEVYNE Therapeutics Inc
$0.56800.22%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
